SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:lup.lub.lu.se:7800f135-c226-4aa9-9690-776ab1f9c57e"
 

Search: id:"swepub:oai:lup.lub.lu.se:7800f135-c226-4aa9-9690-776ab1f9c57e" > The structural basi...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Pang, Siew SiewMonash University (author)

The structural basis for complement inhibition by gigastasin, a protease inhibitor from the giant Amazon leech

  • Article/chapterEnglish2017

Publisher, publication year, extent ...

  • 2017-12-01
  • The American Association of Immunologists,2017
  • 9 s.

Numbers

  • LIBRIS-ID:oai:lup.lub.lu.se:7800f135-c226-4aa9-9690-776ab1f9c57e
  • https://lup.lub.lu.se/record/7800f135-c226-4aa9-9690-776ab1f9c57eURI
  • https://doi.org/10.4049/jimmunol.1700158DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:art swepub-publicationtype
  • Subject category:ref swepub-contenttype

Notes

  • Complement is crucial to the immune response, but dysregulation of the system causes inflammatory disease. Complement is activated by three pathways: classical, lectin, and alternative. The classical and lectin pathways are initiated by the C1r/C1s (classical) and MASP-1/MASP-2 (lectin) proteases. Given the role of complement in disease, there is a requirement for inhibitors to control the initiating proteases. In this article, we show that a novel inhibitor, gigastasin, from the giant Amazon leech, potently inhibits C1s and MASP-2, whereas it is also a good inhibitor of MASP-1. Gigastasin is a poor inhibitor of C1r. The inhibitor blocks the active sites of C1s and MASP-2, as well as the anion-binding exosites of the enzymes via sulfotyrosine residues. Complement deposition assays revealed that gigastasin is an effective inhibitor of complement activation in vivo, especially for activation via the lectin pathway. These data suggest that the cumulative effects of inhibiting both MASP-2 and MASP-1 have a greater effect on the lectin pathway than the more potent inhibition of only C1s of the classical pathway.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Wijeyewickrema, Lakshmi C.La Trobe University (author)
  • Hor, LilianLa Trobe University (author)
  • Tan, SheareenMonash University (author)
  • Lameignere, EmilieUniversity of British Columbia (author)
  • Conway, Edward M.University of British Columbia (author)
  • Blom, Anna M.Lund University,Lunds universitet,Proteinkemi, Malmö,Forskargrupper vid Lunds universitet,Protein Chemistry, Malmö,Lund University Research Groups(Swepub:lu)klke-abl (author)
  • Mohlin, Frida C.Lund University,Lunds universitet,Proteinkemi, Malmö,Forskargrupper vid Lunds universitet,Protein Chemistry, Malmö,Lund University Research Groups(Swepub:lu)med-fbr (author)
  • Liu, XuyuUniversity of Sydney (author)
  • Payne, Richard J.University of Sydney (author)
  • Whisstock, James C.Monash University (author)
  • Pike, Robert N.La Trobe University (author)
  • Monash UniversityLa Trobe University (creator_code:org_t)

Related titles

  • In:Journal of Immunology: The American Association of Immunologists199:11, s. 3883-38910022-17671550-6606

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view